X

Nephrostomy vs Ureterostomy vs Neocystectomy — Complete Comparison Guide

Three methods of urinary diversion — one decision

When the bladder needs to be removed or bypassed, there are three basic options for urinary diversion. Each has different indications, techniques, and impact on daily life. In this article, we compare them in detail to help you understand why your doctor has recommended a particular one.

According to the EAU Guidelines 2024 [1] , the choice of method is individualized and depends on the underlying disease, age, general condition, renal function, urethral anatomy, and personal preferences of the patient.

The 3 methods at a glance

Characteristic 🔵 Nephrostomy (PCN) 🟢 Ureterostomy (Bricker) 🟣 Neocyst
Type External catheter in the kidney Stomach stoma + pouch Neocyst from intestine
Duration Temporary (usually) Permanent Permanent
Invasiveness Minimally invasive (15-30 minutes) Major surgery (4-7 hours) Major surgery (5-9 hours)
Hospitalization 1-3 days 7-9 days 9-14 days
Urination In a bag In an ostomy bag Normal (through the urethra)
Body image Visible bag Discreet bag under clothing No visible change

🔵 Nephrostomy (PCN — Percutaneous Nephrostomy)

Percutaneous nephrostomy is a minimally invasive procedure where a thin catheter is placed from the back directly into the kidney to drain urine when there is obstruction . According to current guidelines [2] , it is mainly used:

  • In urolithiasis in the ureter with hydronephrosis and fever (urgent decompression for urosepsis)
  • In malignant ureteral obstruction (prostate, cervical, lymph node cancer)
  • Before definitive treatment (e.g. chemotherapy, radiotherapy, surgery)
  • In rare cases, as a permanent solution when there is no other option

Advantages: Quick, minimally invasive, low postoperative risk, reversible.
Disadvantages: External bag, catheter change every 2-3 months, swimming restrictions, higher risk of urinary tract infections.

🟢 Ureterostomy (Bricker / Ileal Conduit)

Ureterostomy is the most common method of permanent urinary diversion after radical cystectomy — accounting for >60% worldwide [1] . A section of intestine (~15 cm) is used as a conduit that carries urine from the ureters to a stoma in the abdomen. The patient wears an ostomy bag.

Who is suitable for [3] :

  • Almost all patients who need cystectomy — no strict criteria
  • Elderly with comorbidities that do not tolerate a larger operation
  • Patients with renal dysfunction (eGFR < 45 mL/min)
  • Patients with urethral/sphincter damage or tumor infiltration there
  • Patients who do not want or cannot self-catheterize

Advantages: Technical simpler, safer, shorter hospital stay, quick return to daily life , compatible with a wide range of patients. Quality of life comparable to neobladder after the first months of adaptation [4] .
Disadvantages: Permanent stoma and pouch, need for constant care, psychological adjustment.

🟣 Orthotopic Neobladder

The neobladder is a reservoir made from a section of the intestine that is placed in place of the old bladder and connected to the urethra. The patient urinates normally — although differently (without a feeling of fullness, with scheduling, and possible nocturnal incontinence in the first few months).

Strict eligibility criteria [1] [3] :

  • Age < 75 years (relative criterion)
  • Good renal function ( eGFR > 45 mL/min )
  • Intact external urethral sphincter
  • No urethral tumor infiltration
  • Willing to undergo 6-12 months of voiding training and possible self-catheterization
  • Psychological and motor competence

Advantages: No visible pouch, almost normal urination, better body image, better self-image.
Disadvantages: More complex procedure, longer hospital stay, training time 6-12 months, nocturnal incontinence in 30-50% in the first year, intermittent self-catheterization in 25-30% of patients for complete evacuation, metabolic disorders.

Quality of life: What the studies say

The Cochrane systematic review comparing continent vs incontinent diversion [5] concluded that there is no clear winner in overall quality of life. What matters is:

  • Neocyst is superior in body image and early psychological parameters
  • Ileal conduit is superior in rapid recovery and absence of early postoperative voiding problems
  • At 12-24 months, overall HRQoL becomes comparable — patient adjustment is the most important factor

This is critical: ileal conduit is NOT a “second choice”. It is the right choice for a specific patient profile — and studies show that patients who choose it (either for medical reasons or as a preference) have similar satisfaction to those who have a neocyst.

Complications: Comparison table

Complication Nephrostomy Ureterostomy Neocyst
UTI/infection High risk Moderate Moderate
Parastomal hernia None applicable 15-30% Not applicable
Nocturnal incontinence Not applicable Not applicable 30-50% (first year)
Need for self-catheterization No No 25-30%
Stoma stenosis No applicable 5-10% Not applicable
Kidney stones Rare 5-10% 5-10%
Metabolic acidosis No Rare More common

EOPYY coverage — for all three methods

According to Government Gazette B' 5395/09-10-2025 [6] :

Method EOPYY Coverage Participation
Nephrostomy Catheter + bags + consumables 0%
Urethrostomy €270/month — bags, base plates, consumables 0%
Neocyst Self-catheterization catheters (if needed) 0%

How to choose — 5-question guide

  1. Is the condition temporary or permanent? If you have an obstruction that can be resolved (e.g., stone), nephrostomy is a good temporary solution.
  2. How good is your renal function? If eGFR > 45 mL/min & you are younger, neocyst is an option. Otherwise, ileal conduit.
  3. How important is body image? If the visible pouch is an important psychological factor & you meet the criteria, neocyst.
  4. Are you willing to undergo 6-12 months of training? If not, ileal conduit offers a faster return to daily life.
  5. Do you have other conditions? In the elderly or with comorbidities, ileal conduit is safer.

In any case, the final decision is made together with your urologist — this article is informative to start the discussion in an informed way.

Material selection — How Traumacare helps

At Traumacare, as exclusive representatives of B Braun Avitum in Greece , we support patients with all three methods:

  • Nephrostomy: Catheters, drainage bags, antiseptics, dressing change materials
  • Ureterostomy: Full range Flexima (Uro Silk flat & convex, Active O' convex, Key, 3S, Uribag) with anti-reflux valve and hydrocolloid skin protector
  • Neocyst: Catheters self-catheterization, hygiene materials

In all cases: full management of the EOPYY procedure (e-EOPYY, electronic opinion), express delivery next-day, pre-operative consultation.

Contact for personalized information

🩺 Free consultation for urinary diversion
Exclusive B Braun Avitum representatives · Convatec distribution · Express delivery next-day
✉️ Contact form 💬 Viber channel Traumacare ✓
or by phone: 2311 286262

Related articles

ℹ️ About this article

Author: Vangelis Micharikopoulos, Traumacare — exclusive representatives of B Braun Avitum Greece

Scientific documentation: EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer (2024), EAU Guidelines on Urolithiasis (2024), AUA/ASCO/SUO Guideline on MIBC (2024), NICE NG2 Bladder Cancer (2023), Cochrane Review on continent vs incontinent urinary diversion, Cookingham et al. World J Urol 2022, BAUS patient information

Last updated: May 2026

Note: The content is for informational purposes only and is not a substitute for medical advice. The final choice of urinary diversion method should be made in collaboration with your treating urologist.

📚 Βιβλιογραφία / Επιστημονικές πηγές

  1. EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer . European Association of Urology, 2024. uroweb.org/guidelines
  2. EAU Guidelines on Urolithiasis . European Association of Urology, 2024. uroweb.org/guidelines/urolithiasis
  3. AUA/ASCO/SUO Guideline on Muscle-Invasive Bladder Cancer . American Urological Association, 2017 (amended 2024). auanet.org
  4. Cookingham LM et al. Health-related quality of life in patients with ileal conduit urinary diversion: a systematic review . World Journal of Urology , 2022. pubmed.ncbi.nlm.nih.gov
  5. Yuh BE et al. Continent versus incontinent urinary diversion after radical cystectomy for bladder cancer . Cochrane Database of Systematic Reviews. cochranelibrary.com
  6. ΦΕΚ Β' 5395/09-10-2025 — Καθορισμός υλικών στομίας με κάλυψη ΕΟΠΥΥ . Εθνικό Τυπογραφείο. eopyy.gov.gr
  7. NICE NG2: Bladder cancer — diagnosis and management . National Institute for Health and Care Excellence, 2015 (updated 2023). nice.org.uk/guidance/ng2
  8. BAUS — Information about Urinary Diversion (Ileal Conduit) . British Association of Urological Surgeons. baus.org.uk

Contact form

We have received your message. Thank you!
Welcome to Traumacare

We ask for your permission to use your personal data.

Personalized ads and content, ad and content measurement, audience insights, and product development.

Store information on your device.

Learn more

Your personal data will be processed and information from your device (cookies, unique identifiers and other device data) may be stored, accessed and shared with third party vendors or used specifically by this website or app.

Some vendors may process your personal data based on legitimate interests, to which you may object by managing your choices below. Look for a link at the bottom of this page or in our privacy policy where you can withdraw your consent.


The product has been added to your cart.

Quantity

Save Remove from cart
Quantity in cart: 2 Change
View your cart

Combine your purchases with: